Nutraceuticals Market Research Report - Forecast till 2030

栄養補助食品市場:種類別の情報(ビタミンとミネラル、プロバイオティクス、タンパク質とペプチド、オメガ脂肪酸など)、供給源(植物、動物、微生物)、形態別(カプセル、錠剤、ソフトジェル、粉末、液体およびグミ)、流通チャネル別(店舗ベース [スーパーマーケット&ハイパーマーケット、専門店など] および非店舗ベース)-2030年までの予測

ID: MRFR/F-B & N/1620-CR | February 2021 | Region: Global | 100 Pages         

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVE ANALYSIS 16

1.1.1 GLOBAL NUTRACEUTICALS MARKET, BY TYPE 17

1.1.2 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE 18

1.1.3 GLOBAL NUTRACEUTICALS MARKET, BY FORM 19

1.1.4 GLOBAL NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL 20

1.1.5 GLOBAL NUTRACEUTICALS MARKET, BY REGION 21

1.2 KEY BUYING CRITERIA 22

2 MARKET INTRODUCTION

2.1 DEFINITION 23

2.2 SCOPE OF THE STUDY 23

2.3 MARKET STRUCTURE 23

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 24

3.2 PRIMARY RESEARCH 25

3.3 SECONDARY RESEARCH 26

3.4 MARKET SIZE ESTIMATION 27

3.5 FORECAST MODEL 28

3.6 LIST OF ASSUMPTIONS 28

4 MARKET DYNAMICS

4.1 INTRODUCTION 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF OBESITY 30

4.2.2 FOCUS ON PREVENTIVE HEALTHCARE 30

4.2.3 GROWING AGING POPULATION 31

4.2.4 DRIVERS IMPACT ANALYSIS 31

4.3 RESTRAINTS 31

4.3.1 STRINGENT GOVERNMENT REGULATIONS 31

4.3.2 RESTRAINTS IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 32

4.4.1 EXPANSION OF THE ORGANIZED RETAIL SECTOR IN EMERGING ECONOMIES 32

4.4.2 RISING CONSUMER INCLINATION TOWARD PERSONALIZED NUTRITION 32

4.5 CHALLENGES 33

4.5.1 LIMITED AWARENESS IN UNDERDEVELOPED ECONOMIES 33

4.5.2 NEED FOR HIGH CAPITAL INVESTMENTS 33

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 34

5.1.1 RAW MATERIAL PROCUREMENT 35

5.1.2 PROCESSING 35

5.1.3 PACKAGING 35

5.2 SUPPLY CHAIN ANALYSIS 35

5.3 PORTER’S FIVE FORCES MODEL 36

5.3.1 THREAT OF NEW ENTRANTS 37

5.3.2 BARGAINING POWER OF SUPPLIERS 37

5.3.3 BARGAINING POWER OF BUYERS 37

5.3.4 THREAT OF SUBSTITUTES 37

5.3.5 INTENSITY OF RIVALRY 37

6 NUTRACEUTICALS MARKET, BY TYPE

6.1 OVERVIEW 38

6.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY TYPE, 2020-2027 39

6.2 VITAMINS & MINERALS 39

6.2.1 VITAMINS & MINERALS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 39

6.3 PROBIOTICS 40

6.3.1 PROBIOTICS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 40

6.4 PROTEINS & PEPTIDES 40

6.4.1 PROTEINS & PEPTIDES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 40

6.5 OMEGA FATTY ACIDS 41

6.5.1 OMEGA FATTY ACIDS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 41

6.6 OTHERS 42

6.6.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 42

7 NUTRACEUTICALS MARKET, BY SOURCE

7.1 OVERVIEW 43

7.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY SOURCE, 2020-2027 44

7.2 PLANT 44

7.2.1 PLANT: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 44

7.3 ANIMAL 45

7.3.1 ANIMAL: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 45

7.4 MICROBIAL 46

7.4.1 MICROBIAL: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 46

8 NUTRACEUTICALS MARKET, BY FORM

8.1 OVERVIEW 47

8.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY FORM, 2020-2027 48

8.2 CAPSULES, TABLETS, & SOFTGELS 48

8.2.1 CAPSULES, TABLETS, & SOFTGELS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 48

8.3 POWDER 49

8.3.1 POWDER: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 49

8.4 LIQUID & GUMMIES 50

8.4.1 LIQUID & GUMMIES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 50

9 NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW 51

9.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2020-2027 52

9.2 STORE-BASED 52

9.2.1 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 52

9.3 NON-STORE-BASED 53

9.3.1 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 53

10 GLOBAL NUTRACEUTICALS MARKET, BY REGION

10.1 OVERVIEW 54

10.2 NORTH AMERICA 56

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.1 US 58

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.2 CANADA 60

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.3 MEXICO 62

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3 EUROPE 64

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.1 GERMANY 66

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.2 UK 68

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.3 FRANCE 70

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.4 SPAIN 71

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.5 ITALY 73

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.6 REST OF EUROPE 75

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4 ASIA-PACIFIC 77

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.1 CHINA 79

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.2 INDIA 81

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.3 JAPAN 83

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.4 AUSTRALIA & NEW ZEALAND 84

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.5 REST OF ASIA-PACIFIC 86

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5 REST OF THE WORLD 89

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.1 SOUTH AMERICA 91

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.2 MIDDLE EAST 93

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.3 AFRICA 95

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION 97

11.1.1 MARKET STRATEGY ANALYSIS 97

11.2 COMPETITIVE BENCHMARKING 98

11.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 99

11.3.1 MERGERS & ACQUISITIONS 99

11.3.2 EXPANSIONS 99

11.3.3 JOINT VENTURES 100

11.3.4 PARTNERSHIPS & AGREEMENTS 100

11.3.5 APPROVAL 100

12 COMPANY PROFILES

12.1 PERRIGO COMPANY PLC 101

12.1.1 COMPANY OVERVIEW 101

12.1.2 FINANCIAL OVERVIEW 101

12.1.3 PRODUCTS OFFERED 102

12.1.4 KEY DEVELOPMENTS 102

12.1.5 SWOT ANALYSIS 102

12.1.6 KEY STRATEGIES 102

12.2 GLANBIA PLC 103

12.2.1 COMPANY OVERVIEW 103

12.2.2 FINANCIAL OVERVIEW 103

12.2.3 PRODUCTS OFFERED 104

12.2.4 KEY DEVELOPMENTS 104

12.2.5 SWOT ANALYSIS 105

12.2.6 KEY STRATEGIES 105

12.3 DANONE SA 106

12.3.1 COMPANY OVERVIEW 106

12.3.2 FINANCIAL OVERVIEW 106

12.3.3 PRODUCTS OFFERED 107

12.3.4 KEY DEVELOPMENTS 107

12.3.5 SWOT ANALYSIS 107

12.3.6 KEY STRATEGIES 108

12.4 GLAXOSMITHKLINE PLC 109

12.4.1 COMPANY OVERVIEW 109

12.4.2 FINANCIAL OVERVIEW 109

12.4.3 PRODUCTS OFFERED 110

12.4.4 KEY DEVELOPMENTS 110

12.4.5 SWOT ANALYSIS 111

12.4.6 KEY STRATEGIES 111

12.5 ABBOTT LABORATORIES 112

12.5.1 COMPANY OVERVIEW 112

12.5.2 FINANCIAL OVERVIEW 112

12.5.3 PRODUCTS OFFERED 113

12.5.4 KEY DEVELOPMENTS 114

12.5.5 SWOT ANALYSIS 114

12.5.6 KEY STRATEGIES 115

12.6 DAFLORN LTD 116

12.6.1 COMPANY OVERVIEW 116

12.6.2 FINANCIAL OVERVIEW 116

12.6.3 PRODUCTS OFFERED 116

12.6.4 KEY DEVELOPMENTS 117

12.6.5 KEY STRATEGIES 117

12.7 BACTOLAC PHARMACEUTICAL INC 118

12.7.1 COMPANY OVERVIEW 118

12.7.2 FINANCIAL OVERVIEW 118

12.7.3 PRODUCTS OFFERED 118

12.7.4 KEY DEVELOPMENTS 118

12.7.5 KEY STRATEGIES 119

12.8 YAKULT HONSHA CO., LTD 120

12.8.1 COMPANY OVERVIEW 120

12.8.2 FINANCIAL OVERVIEW 120

12.8.3 PRODUCTS OFFERED 121

12.8.4 KEY DEVELOPMENTS 121

12.8.5 KEY STRATEGIES 122

12.9 MEIJI HOLDINGS CO., LTD 123

12.9.1 COMPANY OVERVIEW 123

12.9.2 FINANCIAL OVERVIEW 123

12.9.3 PRODUCTS OFFERED 124

12.9.4 KEY DEVELOPMENTS 124

12.9.5 KEY STRATEGIES 124

12.10 E.I.D. - PARRY (INDIA) LIMITED 125

12.10.1 COMPANY OVERVIEW 125

12.10.2 FINANCIAL OVERVIEW 125

12.10.3 PRODUCTS OFFERED 126

12.10.4 KEY DEVELOPMENTS 126

12.10.5 KEY STRATEGIES 126

13 REFERENCES

14 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 28

TABLE 2 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY TYPE, 2020-2027 (USD MILLION) 39

TABLE 3 VITAMINS & MINERALS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 4 PROBIOTICS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 5 PROTEINS & PEPTIDES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 6 OMEGA FATTY ACIDS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 7 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 42

TABLE 8 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY SOURCE, 2020-2027 (USD MILLION) 44

TABLE 9 PLANT: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 10 ANIMAL: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 11 MICROBIAL: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 12 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY FORM, 2020-2027 (USD MILLION) 48

TABLE 13 CAPSULES, TABLETS, & SOFTGELS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 14 POWDER: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 49

TABLE 15 LIQUID & GUMMIES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 16 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 52

TABLE 17 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 52

TABLE 18 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 53

TABLE 19 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 55

TABLE 20 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020-2027 (USD MILLION) 56

TABLE 21 NORTH AMERICA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 57

TABLE 22 NORTH AMERICA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 57

TABLE 23 NORTH AMERICA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 57

TABLE 24 NORTH AMERICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 58

TABLE 25 US: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 58

TABLE 26 US: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 59

TABLE 27 US: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 59

TABLE 28 US: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 59

TABLE 29 CANADA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 30 CANADA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 60

TABLE 31 CANADA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 61

TABLE 32 CANADA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 61

TABLE 33 MEXICO: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 34 MEXICO: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 62

TABLE 35 MEXICO: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 62

TABLE 36 MEXICO: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 63

TABLE 37 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020-2027 (USD MILLION) 64

TABLE 38 EUROPE: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 39 EUROPE: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 65

TABLE 40 EUROPE: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 65

TABLE 41 EUROPE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 66

TABLE 42 GERMANY: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 43 GERMANY: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 67

TABLE 44 GERMANY: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 67

TABLE 45 GERMANY: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 67

TABLE 46 UK: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 47 UK: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 68

TABLE 48 UK: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 69

TABLE 49 UK: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 69

TABLE 50 FRANCE: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 51 FRANCE: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 70

TABLE 52 FRANCE: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 70

TABLE 53 FRANCE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 71

TABLE 54 SPAIN: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 55 SPAIN: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 72

TABLE 56 SPAIN: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 72

TABLE 57 SPAIN: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 72

TABLE 58 ITALY: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 59 ITALY: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 73

TABLE 60 ITALY: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 74

TABLE 61 ITALY: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 74

TABLE 62 REST OF EUROPE: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 63 REST OF EUROPE: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 75

TABLE 64 REST OF EUROPE: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 76

TABLE 65 REST OF EUROPE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 76

TABLE 66 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020-2027 (USD MILLION) 77

TABLE 67 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 68 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 78

TABLE 69 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 78

TABLE 70 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 79

TABLE 71 CHINA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 72 CHINA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 80

TABLE 73 CHINA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 80

TABLE 74 CHINA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 80

TABLE 75 INDIA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 81

TABLE 76 INDIA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 81

TABLE 77 INDIA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 82

TABLE 78 INDIA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 82

TABLE 79 JAPAN: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 80 JAPAN: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 83

TABLE 81 JAPAN: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 83

TABLE 82 JAPAN: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 84

TABLE 83 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 84 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 85

TABLE 85 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 85

TABLE 86 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 86

TABLE 87 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 88 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 87

TABLE 89 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 87

TABLE 90 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 88

TABLE 91 REST OF THE WORLD: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2027 (USD MILLION) 89

TABLE 92 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 93 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 90

TABLE 94 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 90

TABLE 95 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 91

TABLE 96 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 91

TABLE 97 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 92

TABLE 98 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 92

TABLE 99 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 92

TABLE 100 MIDDLE EAST: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 93

TABLE 101 MIDDLE EAST: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 93

TABLE 102 MIDDLE EAST: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 94

TABLE 103 MIDDLE EAST: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 94

TABLE 104 AFRICA: NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 105 AFRICA: NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 95

TABLE 106 AFRICA: NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 95

TABLE 107 AFRICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 96

TABLE 108 GLOBAL NUTRACEUTICALS MARKET: MERGERS & ACQUISITIONS 99

TABLE 109 GLOBAL NUTRACEUTICALS MARKET: EXPANSIONS 99

TABLE 110 GLOBAL NUTRACEUTICALS MARKET: JOINT VENTURES 100

TABLE 111 GLOBAL NUTRACEUTICALS MARKET: PARTNERSHIPS & AGREEMENTS 100

TABLE 112 GLOBAL NUTRACEUTICALS MARKET: APPROVAL 100

TABLE 113 PERRIGO COMPANY PLC: PRODUCTS OFFERED 102

TABLE 114 GLANBIA PLC: PRODUCTS OFFERED 104

TABLE 115 GLANBIA PLC: KEY DEVELOPMENTS 104

TABLE 116 DANONE SA: PRODUCTS OFFERED 107

TABLE 117 GLAXOSMITHKLINE PLC: PRODUCTS OFFERED 110

TABLE 118 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 110

TABLE 119 ABBOTT LABORATORIES: PRODUCTS OFFERED 113

TABLE 120 DAFLORN LTD: PRODUCTS OFFERED 116

TABLE 121 BACTOLAC PHARMACEUTICAL, INC: PRODUCTS OFFERED 118

TABLE 122 YAKULT HONSHA CO., LTD: PRODUCTS OFFERED 121

TABLE 123 YAKULT HONSHA CO., LTD: KEY DEVELOPMENTS 121

TABLE 124 MEIJI HOLDINGS CO., LTD: PRODUCTS OFFERED 124

TABLE 125 MEIJI HOLDINGS CO., LTD: KEY DEVELOPMENTS 124

TABLE 126 E.I.D. - PARRY (INDIA) LIMITED: PRODUCTS OFFERED 126

TABLE 127 E.I.D. - PARRY (INDIA) LIMITED: KEY DEVELOPMENTS 126

15 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 16

FIGURE 3 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY TYPE 17

FIGURE 4 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY SOURCE 18

FIGURE 5 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY FORM 19

FIGURE 6 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY DISTRIBUTION CHANNEL 20

FIGURE 7 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY REGION, 2020 21

FIGURE 8 KEY BUYING CRITERIA FOR NUTRACEUTICALS 22

FIGURE 9 GLOBAL NUTRACEUTICALS MARKET: STRUCTURE 23

FIGURE 10 RESEARCH PROCESS 24

FIGURE 11 TOP-DOWN & BOTTOM-UP APPROACHES 27

FIGURE 12 MARKET DYNAMICS OVERVIEW 29

FIGURE 13 DEATHS ATTRIBUTED TO OBESITY, 2020 30

FIGURE 14 DRIVERS IMPACT ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 31

FIGURE 15 RESTRAINTS IMPACT ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 32

FIGURE 16 GLOBAL NUTRACEUTICALS MARKET: VALUE CHAIN 34

FIGURE 17 GLOBAL NUTRACEUTICALS MARKET: SUPPLY CHAIN 35

FIGURE 19 GLOBAL NUTRACEUTICALS MARKET, BY TYPE, 2020 (% SHARE) 38

FIGURE 20 GLOBAL NUTRACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION) 38

FIGURE 21 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE, 2020 (% SHARE) 43

FIGURE 22 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE, 2020-2027 (USD MILLION) 43

FIGURE 23 GLOBAL NUTRACEUTICALS MARKET, BY FORM, 2020 (% SHARE) 47

FIGURE 24 GLOBAL NUTRACEUTICALS MARKET, BY FORM, 2020-2027 (USD MILLION) 47

FIGURE 25 GLOBAL NUTRACEUTICALS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (% SHARE) 51

FIGURE 26 GLOBAL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 51

FIGURE 27 GLOBAL NUTRACEUTICALS MARKET, BY REGION, 2020-2027 (USD MILLION) 54

FIGURE 28 GLOBAL NUTRACEUTICALS MARKET, BY REGION, 2020 (% SHARE) 54

FIGURE 29 NORTH AMERICA: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 56

FIGURE 30 EUROPE: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2018 (% SHARE) 64

FIGURE 31 ASIA-PACIFIC: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 77

FIGURE 32 REST OF THE WORLD: NUTRACEUTICALS MARKET SHARE, BY REGION, 2020 (% SHARE) 89

FIGURE 33 GLOBAL NUTRACEUTICALS MARKET: COMPETITIVE BENCHMARKING 98

FIGURE 34 PERRIGO COMPANY PLC: FINANCIAL OVERVIEW SNAPSHOT 101

FIGURE 35 PERRIGO COMPANY PLC: SWOT ANALYSIS 102

FIGURE 36 GLANBIA PLC: FINANCIAL OVERVIEW SNAPSHOT 103

FIGURE 37 GLANBIA PLC: SWOT ANALYSIS 105

FIGURE 38 DANONE SA: FINANCIAL OVERVIEW SNAPSHOT 106

FIGURE 39 DANONE SA: SWOT ANALYSIS 107

FIGURE 40 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 109

FIGURE 41 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 111

FIGURE 42 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 112

FIGURE 43 ABBOTT LABORATORIES: SWOT ANALYSIS 114

FIGURE 44 YAKULT HONSHA CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 120

FIGURE 45 MEIJI HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 46 E.I.D. - PARRY (INDIA) LIMITED: FINANCIAL OVERVIEW SNAPSHOT 125

栄養補助食品市場

栄養補助食品市場は、2030年までに7.90%のCAGRで繁栄する一方で、437650.0百万米ドルの市場価値を獲得すると予想されています。

セグメンテーション

タイプ別 Vitamins & Minerals Probiotics Proteins & Peptides Omega Fatty Acids Others
By Source Plant Animal Microbial
By Form Capsules Tablets & Softgels Powder Liquid & Gummies
流通チャネル別 Store Based Non Store Based

キープレーヤー

  • Glanbia Plc
  • Abbot Laboratories
  • Perrigo Company Plc
  • Danone SA
  • GlaxoSmithKline Plc
  • Daflorn Ltd
  • Bactolac Pharmaceutical Inc

運転手

  • rise in obesity among people
  • solid performance of the retail sector
  • rise in medical services costs
Speak to Analyst Request a Free Sample

栄養補助食品市場の概要:


栄養補助食品市場は、2030年までに7.90%のCAGRで繁栄する一方で、437650.0百万米ドルの市場価値を獲得すると予想されています。栄養添加物の需要の増加、栄養製品および関連する健康上の利点に対する意識の高まりなど、さまざまな要因が市場の堅実なパフォーマンスに貢献する可能性があります。


栄養補助食品は医薬品の代替品として使用されています。近年、栄養補助食品が大幅に増加しています。それらは、さまざまな種類の慢性的な病状からユーザーを保護し、健康を改善し、老化プロセスを遅らせ、平均余命を延ばし、または体の構造または機能をサポートしながら、ユーザーにいくつかの心理的利益をもたらすことができます。米国疾病予防管理センター(CDC)は、国民健康栄養調査の結果を強調しており、20歳以上の米国の成人の57.6%が栄養補助食品を使用していることを示しています。栄養補助食品の増加は、栄養補助食品市場における需要の増加に重要な役割を果たしてきました。


将来の成長の可能性を確認するために、包括的な栄養補助食品業界の分析が行われました。いくつかの栄養補助食品の市場動向は、将来の市場における市場の成長に影響を与える可能性があるため、分析で検討されています。


コビッド19分析


栄養補助食品市場は、COVID19のパンデミックがプラスの影響を与えた数少ない市場の1つです。感染の有病率が高いため、人々は健康的で栄養価の高い製品への傾向を示しています。栄養補助食品は栄養成分が豊富で免疫力を高めるのに役立つため、市場の需要は予測期間中にさらに急増する可能性があります。したがって、人々がより健康的なライフスタイルを採用するにつれて、栄養補助食品市場の収益は増加すると予想されます。


市場に存在する主な変数


主要な市場推進要因


人々の肥満の増加、小売部門の堅実なパフォーマンス、医療サービスコストの上昇、高齢者の人口の増加など、いくつかの市場ドライバーが栄養補助食品業界の堅実なパフォーマンスにつながると予想されます。予測期間中、市場のプレーヤーは、ドライバーを有利に活用し、栄養補助食品の市場シェアのかなりの部分を獲得するための適切な戦略を考案する必要があります。


マーケットチャレンジ


市場環境には、研究開発活動に取り組むための十分な資金調達や進化する技術環境など、いくつかの課題が存在します。これらの要因は、効果的に対処されるために、将来的に市場関係者によって考慮されなければならない。競争の激しい市場で持続し、生き残るためには、企業は課題を集計し、それに応じて戦略的アプローチを形成する必要があります。


グローバル市場における機会


世界の市場環境には、予測期間中に利用される可能性のある多くの機会が存在します。将来的に市場の成長を促進すると予想される主な機会は、健康的な食事と製品への傾向の高まりです。また、事業者が新しい技術をビジネスプロセスに統合して、高品質の栄養補助食品を市場環境に導入する機会もあります。


拘束


栄養補助食品市場には、その魅力を制限するいくつかの制約があります。主要な制約には、政府によって導入された厳しい規制とガイドライン、および高い生産コストが含まれます。これらの要素はボトルネックとして機能し、予測期間中の市場の成長を制限する可能性があります。ダイナミックな市場で機能する企業は、進化する市場環境に適応できるように、これらの抑制要因を考慮する必要があります。


市場の累積評価


提示された詳細で重要な栄養補助食品市場の見通しレポートは、将来の成長の可能性についての洞察を提供します。市場機会や制約など、そのパフォーマンスに影響を与えるいくつかの要因が特定されています。機会はパフォーマンスにプラスの影響を与える可能性がありますが、制約は市場の成長を妨げる可能性があります。統合された市場評価に基づいて、魅力的な市場設定と見なすことができます。より多くの人々が健康的なライフスタイルに向かって動いているので、市場は今後さらに拡大する余地があります。


主要市場セグメントの概要


タイプ別


栄養補助食品市場は、ビタミンとミネラル、プロバイオティクス、タンパク質とペプチド、オメガ脂肪酸などに分割できます。ビタミンとミネラルのセグメントは、予測期間中に世界市場の成長を促進すると予想されます。「タンパク質とペプチド」セグメントは、将来的に模範的なパフォーマンスを示し、栄養補助食品の市場規模の拡大に貢献することが期待されています。その成長につながる主な要因は、タンパク質が豊富な栄養補助食品の需要の増加です。


ソース別


ソースに基づいて、栄養補助食品市場は植物、動物、および微生物に細分化できます。予測期間中、植物ベースの市場セグメントは指導的地位を占めると予想されます。ビーガン主義に対する人々の高い傾向は、特定の栄養補助食品産業セグメントの成長の可能性を高める触媒として役立つ可能性があります。微生物セグメントは、意識の高まりにより需要が急増する可能性があります。


フォーム別


栄養補助食品市場は、形態に基づいて、カプセル、錠剤とソフトジェル、粉末と液体、およびグミに分割できます。カプセル、錠剤、ソフトジェルのセグメントは、将来的に栄養補助食品業界の成長につながる可能性があります。


流通チャネル別


栄養補助食品市場は、店舗ベースのカテゴリと非店舗ベースのカテゴリに分けることができます。市場の店舗ベースのセグメントは、スーパーマーケットとハイパーマーケット、専門店などにさらに分けることができます。店舗ベースのセグメントは、予測期間中に世界市場のパフォーマンスを推進する上で重要な役割を果たすと予想されます。


地域分析


栄養補助食品市場は、北米、ヨーロッパ、アジア太平洋、その他の世界など、いくつかの地域セグメントに分けることができます。栄養補助食品市場の予測に基づくと、各地域には、その成長とパフォーマンスに影響を与える可能性のあるさまざまな要因が存在する可能性があります。予測される期間中、北米セグメントがグローバルな環境でリードすると予想されます。地域セグメントを支持する主な要因は、地域に著名で成功している企業の存在です。競争の激しいグローバル市場で地域が主導権を握るのに役立つその他の要因は次のとおりです。



  • 人々の座りがちな生活習慣の増加。

  • 多忙なスケジュールの管理。

  • 栄養食品の利点についての認識と知識を高める。


業界における競争の激しさ


世界の栄養補助食品市場における競争の激しさは高く、いくつかの企業が業界で運営されていることは明らかです。事業主体は、ダイナミックなビジネス環境の中で獲得した栄養補助食品の市場シェアを拡大するための戦略的アプローチに取り組んできました。市場参加者の役割は、業界の成長に影響を与えるために最も重要です。世界の栄養補助食品市場で事業を行っている著名なビジネスのいくつかを以下に示します。



  • グランビア

  • アボット・ラボラトリーズ

  • ペリゴ・カンパニー

  • ダノン

  • グラクソ・スミスクライン

  • Daflorn Ltd

  • バクトラック製薬株式会社


最近の市場動向



  • 世界レベルで市場に革命をもたらしている最新の栄養補助食品市場のトレンドの1つは、安定した製剤から半固体および液体製剤にまで及ぶことができる新しいカプセル化技術の開発です。

  • アボットラボラトリーズは、革新的なデジタル技術を統合して、高品質の栄養補助食品ソリューションを顧客に提供しています。


レポート概要


詳細な栄養補助食品市場予測レポートは、市場の主要な変数を把握し、そのパフォーマンスに影響を与えました。グローバル市場の包括的な評価は、市場のマクロ要因、業界で機能する主要ビジネス、および市場で収益性を維持するために採用する戦略的アプローチを調査することによって実行されました。重要な栄養補助食品の市場分析を支援してきた主要な分析ツールには、PESTLE分析モデルとSWOTフレームワークが含まれます。市場の競争力はPorter's Fiの助けを借りて評価されました



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Nutraceuticals market is expected to reach USD 437650.0 billion by 2030.

Nutraceuticals market is expected to exhibit a strong 7.90% CAGR over the forecast period from 2021-2030.

The increasing demand for functional foods and food supplements is the major driver for the nutraceuticals market.

North America holds the largest share in the global nutraceuticals market.

Key players in the nutraceuticals market include GSK, Archer Daniels Midland Company, and BASF, among others.